These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17571246)

  • 1. [Status of glitazones in treatment of type 2 diabetes mellitus].
    Willeke A
    Internist (Berl); 2007 Jul; 48(7):749; author reply 749-50. PubMed ID: 17571246
    [No Abstract]   [Full Text] [Related]  

  • 2. [Consulting Prof. Dr. Stephan Matthaei. Quakenbrück diabetes center. Prescription relevant conclusions].
    Matthaei S
    MMW Fortschr Med; 2007 Apr; 149(15):53. PubMed ID: 17668779
    [No Abstract]   [Full Text] [Related]  

  • 3. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
    Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ;
    Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a german statutory healthcare perspective.
    Neeser K; Lübben G; Siebert U; Schramm W
    Pharmacoeconomics; 2004; 22(5):321-41. PubMed ID: 15061682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone/metformin (Actoplus met).
    Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
    [No Abstract]   [Full Text] [Related]  

  • 6. Choosing first-line therapy for management of type 2 diabetes.
    Graber MA; Darby-Stewart A; Dachs R
    Am Fam Physician; 2008 Jan; 77(1):16-7. PubMed ID: 18236820
    [No Abstract]   [Full Text] [Related]  

  • 7. [ADOPT study. Glitazone controls diabetes progression].
    Einecke D
    MMW Fortschr Med; 2007 Jan; 149(1-2):10, 12, 14. PubMed ID: 17619358
    [No Abstract]   [Full Text] [Related]  

  • 8. Glitazones in type 2 diabetes: an update.
    Drug Ther Bull; 2008 Apr; 46(4):25-9. PubMed ID: 18403615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones for initial treatment of type 2 diabetes?
    Nathan DM
    N Engl J Med; 2006 Dec; 355(23):2477-80. PubMed ID: 17145743
    [No Abstract]   [Full Text] [Related]  

  • 10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling lifetime metabolic progression and cost effectiveness of treatment strategies for type 2 diabetes.
    Palmer AJ; Currie CJ
    Pharmacoeconomics; 2006; 24(9):927-9; author reply 929-35. PubMed ID: 16942126
    [No Abstract]   [Full Text] [Related]  

  • 12. [Too positive comment on glitazones].
    Lindberg M
    Ugeskr Laeger; 2007 Feb; 169(8):733; author reply 733. PubMed ID: 17338040
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 14. [ADOPT study: Reevaluation of antidiabetic drugs. Control of diabetes].
    MMW Fortschr Med; 2007 Apr; 149(15):52-3. PubMed ID: 17668778
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic durability of monotherapy for diabetes.
    Garg R
    N Engl J Med; 2007 Mar; 356(13):1379; author reply 1380. PubMed ID: 17402165
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of guidelines on diabetes medication.
    Giaccari A; Giorda CB; Riccardi G; De Micheli A; Bruno G; Monge L; Frontoni S
    Ann Intern Med; 2012 May; 156(10):752-3; author reply 753. PubMed ID: 22586015
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of guidelines on diabetes medication.
    Brown K; Harbour R; Petrie J
    Ann Intern Med; 2012 May; 156(10):752; author reply 753. PubMed ID: 22586014
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: "Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome", Sinha SK et al., JPEM 2007; 20: 1045-1052.
    Atabek ME
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):100; author reply 100-1. PubMed ID: 18404981
    [No Abstract]   [Full Text] [Related]  

  • 20. Glyburide/metformin HCl clinical overview.
    Seymour A
    Manag Care; 2001 Feb; 10(2 Suppl):11-6. PubMed ID: 11729403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.